HIGHLIGHTS
- who: Kari Luotola from the Faculty of Medicine, Clinicum, University of Helsinki and Helsinki University Hospital, Haartmaninkatu , have published the Article: IL-1 Receptor Antagonist (IL-1Ra) Levels and Management of Metabolic Disorders, in the Journal: Nutrients 2022, 14, 3422. of /2022/
- how: The study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Review Boards.
- future: Future research may evaluate the role of IL-1Ra in actual glucose homeostasis together with routine fasted laboratory tests such as glucose and C-reactive protein (CRP) instead of the oral . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.